Kaye Jack 4
4 · uniQure N.V. · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
uniQure (QURE) Director Jack Kaye Exercises Options, Sells Shares
What Happened Jack Kaye, a director of uniQure N.V. (QURE), exercised 5,295 stock options and immediately sold the resulting 5,295 shares in an open-market transaction on June 17, 2026. The exercise price was $31.71 per share (total cost $167,904) and the shares were sold at a weighted-average price of $42.57 per share (total proceeds $225,408). The gross difference between sale proceeds and exercise cost was about $57,504 before taxes and fees. The filing indicates the shares sold were part of the exercised options (a cashless-type outcome).
Key Details
- Transaction date: June 17, 2026.
- Option exercise: 5,295 shares at $31.71 each (total $167,904) — reported with code M.
- Open-market sale: 5,295 shares at weighted-average $42.57 (total $225,408) — reported with code S; sale prices ranged $42.50–$42.83 per share.
- Derivative disposition: same 5,295-option units shown as disposed at $0, reflecting conversion of the options into shares.
- Shares owned after transaction: Not specified in the filing.
- Filing/timing: Report filed June 22, 2026 — appears to be after the typical two-business-day Form 4 deadline (i.e., filed late).
- Footnotes: Sale was executed under a Rule 10b5-1 trading plan adopted June 16, 2025; option had fully vested on January 25, 2020.
Context This was an exercise-and-sell transaction (options exercised and shares sold immediately), commonly used to monetize vested options. The sale was conducted under a pre-established 10b5-1 plan, which can indicate the trades were preplanned rather than spontaneous market-timing by the insider. As with all insider filings, this is a factual report of the transactions and not a statement of company outlook.
Insider Transaction Report
- Exercise/Conversion
Ordinary Shares
[F1]2026-06-17$31.71/sh+5,295$167,904→ 31,291 total - Sale
Ordinary Shares
[F1][F2]2026-06-17$42.57/sh−5,295$225,408→ 25,996 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F3]2026-06-17−5,295→ 0 totalExercise: $31.71Exp: 2029-01-25→ Ordinary Shares (5,295 underlying)
Footnotes (3)
- [F1]The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.50 to $42.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
- [F3]The Stock Option vested in full on January 25, 2020.